Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Restless legs syndrome.

P Odin1, M Mrowka, M Shing

  • 1Department of Neurology, Central Hospital, Bremerhaven, Germany. per.odin@zkr.de

European Journal of Neurology
|December 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An international 20 country patient and physician survey of the usability and acceptability of Stepped Care pathway in Parkinson's disease.

Scientific reports·2025
Same author

The late stage of Parkinson's -results of a large multinational study on motor and non-motor complications.

Parkinsonism & related disorders·2020
Same author

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre survey.

Journal of neural transmission (Vienna, Austria : 1996)·2020
Same author

[Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) for assessment of non-motor symptoms in dystonia : Intercultural adaptation in the German language].

Der Nervenarzt·2020
Same author

A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study.

Breast cancer research and treatment·2018
Same author

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

European journal of neurology·2018

Restless legs syndrome (RLS) is a common sleep disorder characterized by an urge to move limbs. Dopamine agonists may offer effective RLS treatment with less risk of augmentation compared to levodopa.

Area of Science:

  • Neurology
  • Sleep Medicine
  • Movement Disorders

Background:

  • Restless legs syndrome (RLS) is a prevalent sleep and movement disorder affecting 5-15% of adult white populations.
  • RLS is defined by an irresistible urge to move limbs, often accompanied by sensory disturbances, worsening at rest and during evenings/nights, leading to sleep disturbance and daytime tiredness.
  • The condition often has a familial component, with a fluctuating or progressive disease course.

Purpose of the Study:

  • To provide a general review of Restless Legs Syndrome (RLS).
  • To focus on current treatment options for RLS.
  • To compare the efficacy and side effect profiles of different RLS therapies.

Main Methods:

  • Diagnosis is based on patient history and a normal neurological examination.

Related Experiment Videos

  • Confirmation involves identifying periodic limb movements (PLM) via polysomnography.
  • Treatment response to dopaminergic medication is assessed.

    • Main Results:

    • Levodopa (L-dopa) is effective for RLS, but long-term use can lead to augmentation, worsening symptoms.
    • Dopamine agonists are also effective in RLS therapy.
    • Dopamine agonist treatment appears to carry a lower risk of augmentation compared to L-dopa.

    Conclusions:

    • RLS is a common disorder with significant impact on sleep and daily life.
    • While L-dopa is effective, augmentation is a concern.
    • Dopamine agonists represent a promising alternative treatment for RLS with a potentially better safety profile regarding augmentation.